Search results for: 'research area cell cycle plk'
- BA3993 T2AASummary: T2AA is a monoubiquitinated proliferating cell nuclear antigen inhibitor.
- BA8683 K-80003Summary: Effectively inhibits tRXRα-dependent activation and tumor cell growth.
- BA9051 AMG-Tie2-1Summary: AMG-Tie2-1 is an endothelial endothelial cell kinase 2 inhibitor.
- BA7557 UDP-rhamnoseSummary: UDP-rhamnose is one of the substrates for pectin synthesis in the cell wall.
- BA4367 BRCA1-IN-2Summary: BRCA1-IN-2 is an inhibitor of protein-protein interactions (PPIs) with cell permeability.
- A9934 Zymosan ASummary: A polysaccharide compound extracted from the cell wall of yeast
- F1839 Anti-NCAM1/CD56 Antibody (Lorvotuzumab-MMAE)Summary: Anti-NCAM1/CD56 Antibody (Lorvotuzumab-MMAE)
- F1062 Anti-PSGL1/CD162 Antibody (Neihulizumab)Summary: Anti-PSGL1/CD162 Antibody (Neihulizumab)
- K4411 Concanavalin A (Con A) Solution (500X)Summary: Concanavalin A (Con A) is a potent leukocyte mitogen, which can be used for in vitro activation of human and mouse leukocytes.
- BA9734 MC-1-F2Summary: MC-1-F2 is an inhibitor that reduces epithelial-mesenchymal transition (EMT) labeling, inhibits cancer stem cell (CSC) properties, and decreases invasiveness of denuded resistant prostate cancer (CRPC) cell lines in breast cancer cell lines.